INCISIVE Implementation Guide
0.1.1 - draft

INCISIVE Implementation Guide - Local Development build (v0.1.1) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Breast_Cancer_Type - JSON Representation

Active as of 2023-07-11

Raw json | Download


{
  "resourceType" : "CodeSystem",
  "id" : "BreastCancerType",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-insensitive code system <code>https://fhir.incisive-project.eu/CodeSystem/BreastCancerType</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">IDC<a name=\"BreastCancerType-IDC\"> </a></td><td>Invasive Ductal Carcinoma</td></tr><tr><td style=\"white-space:nowrap\">ILC<a name=\"BreastCancerType-ILC\"> </a></td><td>Invasive Lobular Carcinoma</td></tr><tr><td style=\"white-space:nowrap\">IPLC<a name=\"BreastCancerType-IPLC\"> </a></td><td>Invasive Pleomorphic Lobular Carcinoma</td></tr><tr><td style=\"white-space:nowrap\">IMC<a name=\"BreastCancerType-IMC\"> </a></td><td>Invasive Mixed Carcinoma</td></tr><tr><td style=\"white-space:nowrap\">IUC<a name=\"BreastCancerType-IUC\"> </a></td><td>Invasive  Unidentifiable Carcinoma</td></tr><tr><td style=\"white-space:nowrap\">IBC<a name=\"BreastCancerType-IBC\"> </a></td><td>Inflammatory Breast Carcinoma</td></tr><tr><td style=\"white-space:nowrap\">MPT<a name=\"BreastCancerType-MPT\"> </a></td><td>Malignant Phyllodes Tumour</td></tr><tr><td style=\"white-space:nowrap\">SPC<a name=\"BreastCancerType-SPC\"> </a></td><td>Solid Papillary Carcinoma</td></tr><tr><td style=\"white-space:nowrap\">HBOCS<a name=\"BreastCancerType-HBOCS\"> </a></td><td>Hereditary breast and ovarian cancer syndrome</td></tr><tr><td style=\"white-space:nowrap\">UMN<a name=\"BreastCancerType-UMN\"> </a></td><td>Malignant neoplasms unspecified</td></tr><tr><td style=\"white-space:nowrap\">DCIS<a name=\"BreastCancerType-DCIS\"> </a></td><td>DUCTAL CARCINOMA IN SITU</td></tr><tr><td style=\"white-space:nowrap\">LNH<a name=\"BreastCancerType-LNH\"> </a></td><td>Lymphomas Non-Hodgkin</td></tr><tr><td style=\"white-space:nowrap\">PL<a name=\"BreastCancerType-PL\"> </a></td><td>Preneoplastic lesions (B3 lesionS)</td></tr></table></div>"
  },
  "url" : "https://fhir.incisive-project.eu/CodeSystem/BreastCancerType",
  "version" : "0.1.1",
  "name" : "Breast_Cancer_Type",
  "status" : "active",
  "date" : "2023-07-11",
  "publisher" : "INCISIVE",
  "contact" : [
    {
      "name" : "INCISIVE",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://incisive-project.eu/"
        },
        {
          "system" : "email",
          "value" : "fhir@incisive-project.eu"
        }
      ]
    }
  ],
  "description" : "Breast Cancer Type",
  "caseSensitive" : false,
  "valueSet" : "https://fhir.incisive-project.eu/ValueSet/CancerTypeCodes",
  "content" : "complete",
  "count" : 13,
  "concept" : [
    {
      "code" : "IDC",
      "display" : "Invasive Ductal Carcinoma"
    },
    {
      "code" : "ILC",
      "display" : "Invasive Lobular Carcinoma"
    },
    {
      "code" : "IPLC",
      "display" : "Invasive Pleomorphic Lobular Carcinoma"
    },
    {
      "code" : "IMC",
      "display" : "Invasive Mixed Carcinoma"
    },
    {
      "code" : "IUC",
      "display" : "Invasive  Unidentifiable Carcinoma"
    },
    {
      "code" : "IBC",
      "display" : "Inflammatory Breast Carcinoma"
    },
    {
      "code" : "MPT",
      "display" : "Malignant Phyllodes Tumour"
    },
    {
      "code" : "SPC",
      "display" : "Solid Papillary Carcinoma"
    },
    {
      "code" : "HBOCS",
      "display" : "Hereditary breast and ovarian cancer syndrome"
    },
    {
      "code" : "UMN",
      "display" : "Malignant neoplasms unspecified"
    },
    {
      "code" : "DCIS",
      "display" : "DUCTAL CARCINOMA IN SITU"
    },
    {
      "code" : "LNH",
      "display" : "Lymphomas Non-Hodgkin"
    },
    {
      "code" : "PL",
      "display" : "Preneoplastic lesions (B3 lesionS)"
    }
  ]
}

INCISIVE has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 952179. However, the content of this website reflects the opinion of its authors and does not in any way represent opinions of the European Union. European Commission is not responsible for any use that may be made of the information the website contains.
https://ec.europa.eu/digital-single-market/en/policies/ehealth